Literature DB >> 32937665

Verbena officinalis (Common Vervain) - A Review on the Investigations of This Medicinally Important Plant Species.

Paweł Kubica1, Agnieszka Szopa1, Jakub Dominiak2, Maria Luczkiewicz2, Halina Ekiert1.   

Abstract

Verbena officinalis (common vervain) is a medicinal plant species widely distributed in the world and commonly used in folk medicine of different countries, including traditional Chinese medicine. Monographs on "Verbenae herba" have been included in the European Pharmacopoeia since 2008, and in the Chinese Pharmacopoeia since 1995. This work presents botanical characteristics of this species. It reviews the current knowledge of its chemical composition, which is a rich source mostly of iridoids, phenylpropanoid glycosides, phenolic acids, flavonoids, terpenoids, and essential oil. A large part of this article summarizes traditional medicinal uses and professional pharmacological in vitro and in vivo studies that prove new important applications, e.g., antioxidant, antimicrobial, anti-inflammatory, neuroprotective anticancer, analgesic, or anticonvulsant of verbena herb extracts and individual metabolites. Moreover, emphasis is put on the use of V. officinalis in the food and cosmetics industries, especially due to its antioxidant, antibacterial, and anti-inflammatory properties, and the presence of essential oil with an attractive fragrance composition. This paper also presents the state of biotechnological studies of this species. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32937665     DOI: 10.1055/a-1232-5758

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

1.  Production of Verbascoside, Isoverbascoside and Phenolic Acids in Callus, Suspension, and Bioreactor Cultures of Verbena officinalis and Biological Properties of Biomass Extracts.

Authors:  Paweł Kubica; Agnieszka Szopa; Adam Kokotkiewicz; Natalizia Miceli; Maria Fernanda Taviano; Alessandro Maugeri; Santa Cirmi; Alicja Synowiec; Małgorzata Gniewosz; Hosam O Elansary; Eman A Mahmoud; Diaa O El-Ansary; Omaima Nasif; Maria Luczkiewicz; Halina Ekiert
Journal:  Molecules       Date:  2020-11-28       Impact factor: 4.411

2.  Characterization of the chloroplast genome of Verbena officinalis Linn. (Verbenaceae) and its phylogenetic analysis.

Authors:  Zhizheng Fang; Guangrong Qian; Nianjun Yu; Rongchun Han; Dezhu Ge
Journal:  Mitochondrial DNA B Resour       Date:  2021-05-23       Impact factor: 0.658

3.  Phenylpropanoid Glycoside and Phenolic Acid Profiles and Biological Activities of Biomass Extracts from Different Types of Verbena officinalis Microshoot Cultures and Soil-Grown Plant.

Authors:  Paweł Kubica; Adam Kokotkiewicz; Magdalena Anna Malinowska; Alicja Synowiec; Małgorzata Gniewosz; Shah Hussain; Muhammad Yaqoob; Günther K Bonn; Thomas Jakschitz; Eman A Mahmoud; Tarek K Zin El-Abedin; Hosam O Elansary; Maria Luczkiewicz; Halina Ekiert; Agnieszka Szopa
Journal:  Antioxidants (Basel)       Date:  2022-02-17

4.  Poly(vinyl alcohol)/Plant Extracts Films: Preparation, Surface Characterization and Antibacterial Studies against Gram Positive and Gram Negative Bacteria.

Authors:  Mihaela Barbălată-Mândru; Diana Serbezeanu; Maria Butnaru; Cristina Mihaela Rîmbu; Alexandru Alin Enache; Magdalena Aflori
Journal:  Materials (Basel)       Date:  2022-03-28       Impact factor: 3.623

5.  Integrating transcriptome and chemical analyses to reveal the anti-Alzheimer's disease components in Verbena officinalis Linn.

Authors:  Shuhuan Peng; Fangyi Li; Kuo Yu; Fengshu Zhou; Heshui Yu; Hui Liu; Jialiang Guo; Guoqiang Li; Chunhua Wang; Xiaohui Yan; Zheng Li
Journal:  Front Plant Sci       Date:  2022-08-04       Impact factor: 6.627

Review 6.  Nanoemulsion as an Effective Inhibitor of Biofilm-forming Bacterial Associated Drug Resistance: An Insight into COVID Based Nosocomial Infections.

Authors:  Deena Santhana Raj; Duraisami Dhamodharan; S Thanigaivel; A S Vickram; Hun-Soo Byun
Journal:  Biotechnol Bioprocess Eng       Date:  2022-09-07       Impact factor: 3.386

7.  Verbena Attenuates Adriamycin-Induced Renal Tubular Injury via Inhibition of ROS-ERK1/2-NLRP3 Signal Pathway.

Authors:  Yicen Zhou; Qijing Wu; Zhenfang Du; Min Huang; Kun Gao; Xiaowei Ma; Hui Zhang; Sheng Qiang; Wei Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-28       Impact factor: 2.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.